Our leadership has a combined 100+ years of experience in R&D, CMC, clinical and commercialization of medicines. We are experienced in diverse modalities such as small molecules, nucleic acids, peptides, vaccines, monoclonal and bispecific antibodies, recombinant proteins, antigen-heteropolymers, antibody drug conjugates, cell-gene, herbal/natural, and combination therapies. Our focus is on achieving the highest possible success of medicines in patients.